Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2014 1
2022 2
2023 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Pagliari MT, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour MR, Benítez Hidalgo O, Biguzzi E, Bodó I, Castaman G, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Mannucci PM, Federici AB, Eikenboom J, Peyvandi F. Pagliari MT, et al. J Thromb Haemost. 2023 Apr;21(4):787-799. doi: 10.1016/j.jtha.2023.01.001. Epub 2023 Jan 11. J Thromb Haemost. 2023. PMID: 36792472 Free article.
Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study.
Pagliari MT, Rosendaal FR, Ahmadinejad M, Badiee Z, Baghaipour MR, Baronciani L, Benítez Hidalgo O, Bodó I, Budde U, Castaman G, Eshghi P, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Peyvandi F, Federici AB, Eikenboom J. Pagliari MT, et al. J Thromb Haemost. 2022 May;20(5):1106-1114. doi: 10.1111/jth.15658. Epub 2022 Feb 22. J Thromb Haemost. 2022. PMID: 35092343 Free PMC article.
Acute mountain sickness in Iranian trekkers around Mount Damavand (5671 m) in Iran.
Ziaee V, Yunesian M, Ahmadinejad Z, Halabchi F, Kordi R, Alizadeh R, Afsharjoo HR. Ziaee V, et al. Wilderness Environ Med. 2003 Winter;14(4):214-9. doi: 10.1580/1080-6032(2003)14[214:amsiit]2.0.co;2. Wilderness Environ Med. 2003. PMID: 14719853
The questionnaires were filled out in 3 steps, first at 2900 m and then during both ascent and descent at 4200 m. RESULTS: The overall incidence of AMS was 60.8%. ...Incidence was weakly dependent on rate of ascent (from 2900 m up to 4200 m in less tha …
The questionnaires were filled out in 3 steps, first at 2900 m and then during both ascent and descent at 4200 m. RESULTS: The …
A randomized controlled clinical trial of the effects of range of motion exercises and massage on muscle strength in critically ill patients.
Rahiminezhad E, Sadeghi M, Ahmadinejad M, Mirzadi Gohari SI, Dehghan M. Rahiminezhad E, et al. BMC Sports Sci Med Rehabil. 2022 May 26;14(1):96. doi: 10.1186/s13102-022-00489-z. BMC Sports Sci Med Rehabil. 2022. PMID: 35619171 Free PMC article.
Using a hand-held dynamometer, the co-researcher, rated the muscle strength before, on the fourth and seventh days of intervention at 8 p.m. RESULTS: The mean muscles strength of the right arm in the ROM exercise and massage groups increased by 0.63 kg, and 0.29 kg, respec …
Using a hand-held dynamometer, the co-researcher, rated the muscle strength before, on the fourth and seventh days of intervention at 8 p. …
Differences in Mental Health, Risk Behaviors, and Social Determinants Among Anabolic-Androgenic Steroid Consumers With and Without Co-occurring Methamphetamine Use in Australia.
Bonenti B, Kerswell N, Shuttleworth G, Murphy G, Barnett A, Ahmadinejad B, Piatkowski T. Bonenti B, et al. J Dual Diagn. 2026 Jul-Sep;22(3):226-235. doi: 10.1080/15504263.2026.2686090. Epub 2026 Jun 18. J Dual Diagn. 2026. PMID: 42314007
This study compared people who co-use AAS with methamphetamine (AAS-M) and without (AAS-non-meth [AAS-NM]) across mental health, risk behaviors, and social determinants. ...Finally, loneliness indicators were significantly higher among AAS-M clients (t-tests, both p …
This study compared people who co-use AAS with methamphetamine (AAS-M) and without (AAS-non-meth [AAS-NM]) across mental health, risk …
The Trenbolo(g)ne Sandwich: An International Study Comparing Health Harms Among Men Who Use Anabolic-Androgenic Steroids With and Without Trenbolone.
Bonenti B, Ahmadinejad B, Puljević C, Ferris J, Winstock A, Ganson KT, Nagata JM, Bradshaw A, Piatkowski T. Bonenti B, et al. Drug Alcohol Rev. 2026 May;45(4):e70162. doi: 10.1111/dar.70162. Drug Alcohol Rev. 2026. PMID: 42037159 Free PMC article.
METHODS: Data were drawn from male respondents to the Global Drug Survey 2024 who reported past-year AAS consumption (N = 1146; M(age) = 31.46, SD = 9.93). Participants were categorised as the trenbolone group (n = 237) or non-trenbolone group (n = 909) based on past-12-mo …
METHODS: Data were drawn from male respondents to the Global Drug Survey 2024 who reported past-year AAS consumption (N = 1146; M(age …
Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial.
Shohrati M, Moshkani M, Pishgoo B, Ahmadinejad M, Najafian N, Najafian B, Kazemisaleh D. Shohrati M, et al. Iran Red Crescent Med J. 2014 Feb;16(2):e15277. doi: 10.5812/ircmj.15277. Epub 2014 Feb 7. Iran Red Crescent Med J. 2014. PMID: 24719748 Free PMC article.
RESULTS: In groups A and B, the mean levels of PRP before the study were 348000 and 340000/ L respectively. The ADPs were also 73/76 and 68/07 M that showed no significant difference (P > 0.05).The Means of ADP5 in group A before and after the study were 66.40 and 43.8 …
RESULTS: In groups A and B, the mean levels of PRP before the study were 348000 and 340000/ L respectively. The ADPs were also 73/76 and 68/ …